Vincent J. Kalish
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, PARP inhibition in cancer therapy, HIV Research and Treatment, Synthesis and Catalytic Reactions, Signaling Pathways in Disease
Most-Cited Works
- → Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex(1995)760 cited
- → Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease(1997)619 cited
- → Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease(1996)209 cited
- Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.(2003)
- → Improved Procedure for the Reduction of N-Acyloxazolidinones(1990)143 cited
- → First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease(2005)106 cited
- → One-pot synthesis of protected prostaglandins from alkynes and cyclopentenones. In situ generation of higher order cyanocuprates derived from alkenylzirconium intermediates(1990)67 cited
- → Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors(1996)61 cited
- → Design and Synthesis of Poly ADP-ribose Polymerase-1 Inhibitors. 2. Biological Evaluation of Aza-5[H]-phenanthridin-6-ones as Potent, Aqueous-Soluble Compounds for the Treatment of Ischemic Injuries(2003)58 cited
- → Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. part 4: Biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries(2003)55 cited